Page last updated: 2024-08-24

topotecan and Hypertension, Pulmonary

topotecan has been researched along with Hypertension, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Dai, A; Jiang, Y; Li, C; Li, W; Liu, L; Liu, N; Pan, D; Peng, G; Ran, P; Tian, H; Yang, X; Zhou, Y	1

Other Studies

1 other study(ies) available for topotecan and Hypertension, Pulmonary

Article	Year
Topotecan prevents hypoxia-induced pulmonary arterial hypertension and inhibits hypoxia-inducible factor-1α and TRPC channels. The international journal of biochemistry & cell biology, 2018, Volume: 104 Topics: Animals; Calcium; Cell Hypoxia; Cell Movement; Cell Proliferation; Cytokines; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocytes, Smooth Muscle; Phenotype; Rats; Rats, Wistar; Topotecan; TRPC Cation Channels; Vascular Endothelial Growth Factor A; Vascular Remodeling	2018

Article

Year

Topotecan prevents hypoxia-induced pulmonary arterial hypertension and inhibits hypoxia-inducible factor-1α and TRPC channels.

The international journal of biochemistry & cell biology, 2018, Volume: 104

Topics: Animals; Calcium; Cell Hypoxia; Cell Movement; Cell Proliferation; Cytokines; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocytes, Smooth Muscle; Phenotype; Rats; Rats, Wistar; Topotecan; TRPC Cation Channels; Vascular Endothelial Growth Factor A; Vascular Remodeling

2018